| Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004 KL Ong, BMY Cheung, YB Man, CP Lau, KSL Lam Hypertension 49 (1), 69-75, 2007 | 2162 | 2007 |
| Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006 BMY Cheung, KL Ong, SS Cherny, PC Sham, AWK Tso, KSL Lam The American journal of medicine 122 (5), 443-453, 2009 | 467 | 2009 |
| Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension KL Ong, AWK Tso, KSL Lam, BMY Cheung Hypertension 51 (4), 1142-1148, 2008 | 333 | 2008 |
| Prevalence, treatment, and control of diagnosed diabetes in the US National Health and Nutrition Examination Survey 1999–2004 KL Ong, BMY Cheung, LYF Wong, NMS Wat, KCB Tan, KSL Lam Annals of epidemiology 18 (3), 222-229, 2008 | 279 | 2008 |
| High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects C Chen, BMY Cheung, AWK Tso, Y Wang, LSC Law, KL Ong, NMS Wat, ... Diabetes care 34 (9), 2113-2115, 2011 | 209 | 2011 |
| Urotensin II: its function in health and its role in disease KL Ong, KSL Lam, BMY Cheung Cardiovascular drugs and therapy 19, 65-75, 2005 | 142 | 2005 |
| Prevalence, awareness, treatment, and control of hypertension: United States national health and nutrition examination survey 2001–2002 BMY Cheung, KL Ong, YB Man, KSL Lam, CP Lau The Journal of Clinical Hypertension 8 (2), 93-98, 2006 | 120 | 2006 |
| Obesity susceptibility genetic variants identified from recent genome-wide association studies: implications in a chinese population CYY Cheung, AWK Tso, BMY Cheung, A Xu, KL Ong, CHY Fong, ... The Journal of Clinical Endocrinology & Metabolism 95 (3), 1395-1403, 2010 | 117 | 2010 |
| Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese KL Ong, M Li, AWK Tso, A Xu, SS Cherny, PC Sham, HF Tse, TH Lam, ... European Journal of Endocrinology 163 (2), 251-257, 2010 | 113 | 2010 |
| Arthritis: its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008 KL Ong, BJ Wu, BMY Cheung, PJ Barter, KA Rye Annals of epidemiology 23 (2), 80-86, 2013 | 108 | 2013 |
| Circulating microRNAs as biomarkers of Alzheimer’s disease: a systematic review HZY Wu, KL Ong, K Seeher, NJ Armstrong, A Thalamuthu, H Brodaty, ... Journal of Alzheimer's Disease 49 (3), 755-766, 2016 | 103 | 2016 |
| Fibroblast growth factor 21 in non-alcoholic fatty liver disease B Tucker, H Li, X Long, KA Rye, KL Ong Metabolism 101, 153994, 2019 | 98 | 2019 |
| High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1 BJ Wu, K Chen, S Shrestha, KL Ong, PJ Barter, KA Rye Circulation research 112 (2), 278-288, 2013 | 91 | 2013 |
| Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999–2004 BMY Cheung, KL Ong, LYF Wong International journal of cardiology 135 (2), 156-161, 2009 | 90 | 2009 |
| The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study KL Ong, AS Januszewski, R O’Connell, AJ Jenkins, A Xu, DR Sullivan, ... Diabetologia 58, 464-473, 2015 | 89 | 2015 |
| Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes KL Ong, KA Rye, R O'Connell, AJ Jenkins, C Brown, A Xu, DR Sullivan, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4701-4708, 2012 | 87 | 2012 |
| The role of fibroblast growth factor 21 in atherosclerosis J Kokkinos, S Tang, KA Rye, KL Ong Atherosclerosis 257, 259-265, 2017 | 72 | 2017 |
| Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance KL Ong, LYF Wong, YB Man, RYH Leung, YQ Song, KSL Lam, ... Peptides 27 (7), 1659-1667, 2006 | 72 | 2006 |
| APOA1: a protein with multiple therapeutic functions BJ Cochran, KL Ong, B Manandhar, KA Rye Current Atherosclerosis Reports 23, 1-10, 2021 | 71 | 2021 |
| Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study C Chen, AWK Tso, LSC Law, BMY Cheung, KL Ong, NMS Wat, ED Janus, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), 5074-5081, 2010 | 71 | 2010 |
Pak ShamDepartment of Psychiatry, The University of Hong KongVerified email at hku.hk
